Company profilePharmaceutical#456 of 1,318 in Pakistan✓ No DRAP alerts

CSH PHARMACEUTICALS-NORTH (PVT) LTD

Pharmaceutical company · 32 brands · 28 molecules

Ranked #14 of 39 companies in Calcium Channel Blockers

32 registered products 17 pharmaceutical brands 28 distinct molecules 0 DRAP alerts

Company overview

32
registered products
17
pharmaceutical brands
28
distinct molecules
5
therapeutic classes
0
DRAP alerts

CSH PHARMACEUTICALS-NORTH (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 32 product registrations across 28 distinct molecules. Its portfolio is concentrated in Calcium Channel Blockers and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Therapeutic classes

Calcium Channel Blockers · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Drugs For Constipation · 1Ace Inhibitor · 1Other Beta-Lactam, Cephalosporins & Penems · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for CSH

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.